IRIS Accounts Production v24.2.0.383 09355671 Board of Directors 1.1.23 31.12.23 31.12.23 30.9.2024 0 3 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093556712022-12-31093556712023-12-31093556712023-01-012023-12-31093556712021-12-31093556712022-01-012022-12-31093556712022-12-3109355671ns15:EnglandWales2023-01-012023-12-3109355671ns14:PoundSterling2023-01-012023-12-3109355671ns10:Director12023-01-012023-12-3109355671ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3109355671ns10:SmallEntities2023-01-012023-12-3109355671ns10:Audited2023-01-012023-12-3109355671ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3109355671ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3109355671ns10:AbridgedAccounts2023-01-012023-12-310935567112023-01-012023-12-3109355671ns10:Director22023-01-012023-12-3109355671ns10:RegisteredOffice2023-01-012023-12-3109355671ns5:CurrentFinancialInstruments2023-12-3109355671ns5:CurrentFinancialInstruments2022-12-3109355671ns5:ShareCapital2023-12-3109355671ns5:ShareCapital2022-12-3109355671ns5:RetainedEarningsAccumulatedLosses2023-12-3109355671ns5:RetainedEarningsAccumulatedLosses2022-12-3109355671ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3109355671ns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3109355671ns5:ComputerSoftware2023-01-012023-12-31
REGISTERED NUMBER: 09355671 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

PROMEDICA PLUS UK LIMITED

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2023










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


PROMEDICA PLUS UK LIMITED

COMPANY INFORMATION
For The Year Ended 31 December 2023







DIRECTORS: K E Twardowska
G Wrzosek





REGISTERED OFFICE: Suite 38 Hardmans Business Centre
New Hall Hey Road
Rawtenstall
Lancashire
BB4 6HH





REGISTERED NUMBER: 09355671 (England and Wales)

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

ABRIDGED BALANCE SHEET
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 3 - 6,146
Tangible assets 4 - -
- 6,146

CURRENT ASSETS
Debtors 171,258 157,466
Cash at bank 5,529 1,111
176,787 158,577
CREDITORS
Amounts falling due within one year 111,530 113,366
NET CURRENT ASSETS 65,257 45,211
TOTAL ASSETS LESS CURRENT
LIABILITIES

65,257

51,357

PROVISIONS FOR LIABILITIES - 1,203
NET ASSETS 65,257 50,154

CAPITAL AND RESERVES
Called up share capital 5,000 5,000
Retained earnings 60,257 45,154
SHAREHOLDERS' FUNDS 65,257 50,154

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2024 and were signed on its behalf by:





G Wrzosek - Director


PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2023


1. STATUTORY INFORMATION

Promedica Plus UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is made up of sales of franchise fees and intragroup recharges, excluding value added tax.

Sales of franchise fees are comprised of an initial setup fee, which is recognised on the date the agreement is signed, and ongoing monthly management and marketing fees which are included on a monthly basis with adjustments made for accrued or deferred income.

Intragroup recharges
The company incurs costs throughout the year which relate to the UK based operation and these are recharged monthly to the other UK based trading companies and shown within 'Turnover'.

The recharges are calculated based on the turnover of each individual company as a percentage of the total turnover of all UK trading companies, in line with a formula which is defined in the intercompany agreement. At the end of the year, Management reserve the right to make an adjustment to the recharge to ensure that the costs in each of the individual companies are in line with the turnover of that company.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of one years.

Computer software is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets
Tangible fixed assets are stated at cost or valuation less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended by management.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.

Fixtures and fittings -25% on cost

Financial instruments
The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods.

Deferred tax represents the future tax consequences of material transactions and events recognised in the financial statements of current and previous periods.

Current and deferred tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2023


3. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023
and 31 December 2023 53,105
AMORTISATION
At 1 January 2023 46,959
Amortisation for year 6,146
At 31 December 2023 53,105
NET BOOK VALUE

At 31 December 2023 -
At 31 December 2022 6,146

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023
and 31 December 2023 2,073
DEPRECIATION
At 1 January 2023
and 31 December 2023 2,073
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 -

5. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Katharine Halsall (Senior Statutory Auditor)
for and on behalf of Caldwell Penn Limited, Statutory Auditor

6. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

At the balance sheet date, the amounts due from group companies amounted to £141,791 (2022 - £125,046). This amount is included in 'Balances due from group undertakings'.

At the balance sheet date, the amounts due to group companies amounted to £3,550 (2022 - £nil). This amount is included in 'Balances due to group undertakings'.

7. ULTIMATE PARENT UNDERTAKING

The ultimate parent undertaking is PineBridge New Europe Partners II-A, L.P., a company registered in the state of Cayman Islands. The parent's business and mailing address is 399 Park Avenue, 4th Floor, New York, NY, 10022.